Alliance Pharma PLC has announced the appointment of Camillo Pane as the new Chair of the Board, effective from 19th February 2024. The company has transitioned from a Prescription Medicines business to a fast-growing Consumer Healthcare company, with Consumer Healthcare revenues representing 75% of Group revenues in 2023. Jo LeCouilliard, who has been instrumental in driving this transition, will step down from the Board, and Camillo Pane will lead the company through its next strategic phase, focusing on organic growth through marketing and innovation.
Camillo Pane brings over thirty years of experience in US, European, and Asian public, multinational Consumer companies. He has held senior positions at Reckitt Benckiser and Coty Inc, and most recently served as Group CEO of Health & Happiness Group. Richard Jones, Senior Independent Director of Alliance, expressed gratitude to Jo for her significant contribution and welcomed Camillo, stating that the Board remains focused on creating value for shareholders by investing in growth while carefully managing the cost base.
Alliance Pharma PLC, headquartered in the UK, is a growing consumer healthcare company with a purpose to empower people to make a positive difference to their health and wellbeing by making trusted and proven brands available worldwide. The Group employs around 285 people across Europe, North America, and the Asia Pacific region and focuses on organic growth through investing in priority brands and channels, related innovation, and selective geographic expansion. Periodically, the company may look to enhance organic growth through selective, complementary acquisitions.